Other News Releases in Health Care & Hospitals
Amid the Flu Epidemic, Don't Forget RSV in Young Children
Congressman Fattah: Thanks to Specter, Casey for a Major Step Along History's Path
Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure
Other News Releases in FDA Approval
American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products
Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
See more news releases in: Health Care & Hospitals, Medical Pharmaceuticals, FDA Approval
Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
Delsym is the only FDA-approved 12-hour non-prescription liquid cough
suppressant
CHESTER, N.J., Oct. 1 /PRNewswire-FirstCall/ -- Adams Respiratory
Therapeutics, Inc. ( ARxT) today announced that the Food and Drug
Administration (FDA) approved its supplemental New Drug Application for a
grape-flavored formulation of Delsym Extended-Release Suspension on Friday,
Sept. 28, 2007. The Company will immediately commence distribution of grape
Delsym product to its trade customers.
Delsym is the first and only over-the-counter (OTC) liquid that
controls cough for a full 12 hours with a single dose, providing all day or
all night cough suppression with each dose. Delsym's patented
single-ingredient formula delivers great tasting medicine in orange and now
new grape flavors for both children and adults.
About Adams Respiratory Therapeutics, Inc.
Adams is a specialty pharmaceutical company focused on the late-stage
development, commercialization and marketing of over-the-counter and
prescription pharmaceuticals for the treatment of respiratory disorders.
SOURCE Adams Respiratory Therapeutics, Inc.